IGF-1 LR3

IGF-1 LR3 – Research Peptide

IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a synthetic research peptide engineered to enhance stability, potency, and biological activity compared to native IGF-1. With a modified amino acid sequence that significantly reduces binding affinity to IGF-binding proteins (IGFBPs), IGF-1 LR3 allows researchers to study unrestricted IGF-1 pathway activity, making it a centerpiece in advanced cellular and metabolic research.

Researchers use IGF-1 LR3 to investigate:

• Cellular growth, proliferation, and differentiation pathways

• Protein synthesis and anabolic signaling

• Muscle cell regeneration and repair mechanisms

• Insulin-like metabolic pathways

• Interaction with IGF-1 receptors independent of IGFBP inhibition

Because of its extended half-life and reduced IGFBP binding, IGF-1 LR3 provides a highly stable platform for studying tissue growth, recovery models, and advanced metabolic signaling across controlled in-vitro environments.

Key Research Points

• Modified IGF-1 analog with extended activity

• Low binding affinity to IGF-binding proteins

• Studied for cell growth, repair, and anabolic signaling

• Useful in muscle, tissue, and metabolic research models

• High-purity peptide ideal for advanced laboratory applications

Specifications

• Compound: IGF-1 LR3

• Form: Lyophilized Peptide Powder

• Purity: >98% (HPLC Verified)

• Storage: Store in a cool, dry location. Refrigeration recommended for long-term stability.

Important Notice

This product is strictly for laboratory, research, and in-vitro use only.
Not for human consumption.
Not for animal use.
Not for medical or diagnostic purposes.